PUREVAX Feline 4 (0.5 mL)This page contains information on PUREVAX Feline 4 (0.5 mL) for veterinary use.
The information provided typically includes the following:
- PUREVAX Feline 4 (0.5 mL) Indications
- Warnings and cautions for PUREVAX Feline 4 (0.5 mL)
- Direction and dosage information for PUREVAX Feline 4 (0.5 mL)
PUREVAX Feline 4 (0.5 mL)This treatment applies to the following species:
Feline Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Vaccine
Modified Live Virus, Modified Live Chlamydia
PUREVAX Feline 4 (0.5 mL) Indications
This product has been shown to be effective for the vaccination of healthy cats 6 weeks of age and older against feline rhinotracheitis, calici, and panleukopenia viruses and Chlamydia psittaci. The duration of immunity has not been determined. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.
PureVax® Feline 4 contains a lyophilized suspension of modified live feline rhinotracheitis, calici, and panleukopenia viruses and Chlamydia psittaci, each propagated in a stable cell line, plus sterile water diluent. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge tests in susceptible cats.
Directions and dosage: Aseptically rehydrate the lyophilized vaccine with 0.5 mL of the accompanying sterile diluent, and agitate. Administer 1 dose subcutaneously or intramuscularly into healthy cats.
For primary vaccination, revaccinate with a second dose 3 to 4 weeks later. The presence of maternal antibody is known to interfere with the development of active immunity in cats and additional boosters will be required in most young animals. For advice on revaccination frequency, consult your veterinarian.
PrecautionsUse entire contents immediately after reconstitution. Contains gentamicin as a preservative. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine. In case of human exposure, contact a physician. Inactivate unused contents before disposal.
Store at 2-8°C (35-46°F). Do not use chemicals to sterilize syringes and needles. Do not mix with other products, except as specified on the label. Do not vaccinate pregnant cats.
For use in animals only. Sold to veterinarians only.
PUREVAX® is a registered trademark of the Boehringer Ingelheim Animal Health France SCS, used under license.
Boehringer Ingelheim Animal Health USA Inc., Athens, GA 30601 USA
Tel.: 1 (888) 637-4251
Distributed in Canada by:
Boehringer Ingelheim Animal Health Canada Inc., Burlington ON L7L 5H4
25 x 1 Dose, Lyophilized
25 x 0.5 mL, Sterile Diluent
3239 SATELLITE BLVD., BLDG 500, DULUTH, GA, 30096
Copyright © 2023 Animalytix LLC. Updated: 2023-11-27